Biofidelity is a revolutionary genomic technology company dedicated to removing the noise from genomic analysis to unleash its potential to transform human health. Our platform technology can be used on existing instrumentation in laboratories around the world, making genomic data far more accessible, far lower cost, and bringing the benefits of precision medicine to far more patients.
Founded in 2019, Biofidelity is a rapidly growing company of scientists, engineers, physicians and commercial experts dedicated to making genomics globally accessible, and to becoming the dominant provider of reagent-based solutions in oncology.
For more information, please visit biofidelity.com and connect with us on LinkedIn and Twitter. For media inquiries please reach out to media@biofidelity.com.